Vesicular stomatitis virus–based vaccines against lassa and ebola viruses

Andrea Marzi, Friederike Feldmann, Thomas W. Geisbert, Heinz Feldmann, David Safronetz

Research output: Contribution to journalArticlepeer-review

45 Scopus citations


We demonstrated that previous vaccination with a vesicular stomatitis virus (VSV)-based Lassa virus vaccine does not alter protective efficacy of subsequent vaccination with VSV-based Ebola virus vaccine. These findings demonstrate the utility of VSV-based vaccines against divergent viral pathogens, even when preexisting immunity to the vaccine vector is present.

Original languageEnglish (US)
Pages (from-to)305-307
Number of pages3
JournalEmerging infectious diseases
Issue number2
StatePublished - 2015

ASJC Scopus subject areas

  • Epidemiology
  • Microbiology (medical)
  • Infectious Diseases


Dive into the research topics of 'Vesicular stomatitis virus–based vaccines against lassa and ebola viruses'. Together they form a unique fingerprint.

Cite this